(Q39461620)

12 September 2017

Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA. (English)

1 reference

12 September 2017

0 references

1 reference

4

Tamara Minko

1 reference

12 September 2017

Oleh Taratula

1

1 reference

12 September 2017

Olga B Garbuzenko

series ordinal

2

1 reference

12 September 2017

Alex M Chen

series ordinal

3

1 reference

12 September 2017

10 October 2011

1 reference

Journal of Drug Targeting

12 September 2017

1 reference

12 September 2017

19

1 reference

12 September 2017

10

1 reference

12 September 2017

900-914

1 reference

Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug

12 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Endocytic mechanisms for targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Toxicological hazards of inhaled nanoparticles--potential implications for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Targeted proapoptotic anticancer drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Potential clinical applications of siRNA technique: benefits and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

The re-emergence of aerosol gene delivery: a viable approach to lung cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

First line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer--a new standard of care?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Endocytosis and cationic cell-penetrating peptides--a merger of concepts and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Thermosensitive sterically stabilized liposomes: formulation and in vitro studies on mechanism of doxorubicin release by bovine serum and human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Paclitaxel (taxol) and taxoid derivates for lung cancer treatment: potential for aerosol delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

BCL-2 family members and the mitochondria in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Nanocarriers' entry into the cell: relevance to drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

ATTEMPTS system: a macromolecular prodrug strategy for cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Recent advances in tumor-targeting anticancer drug conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Gene silencing efficiency of siRNA-PEG conjugates: effect of PEGylation site and PEG molecular weight

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Camptothecins and lung cancer: improved delivery systems by aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Update on the development of microRNA and siRNA molecules as regulators of cell physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Refinement of an orthotopic lung cancer model in the nude rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Treatment of locally advanced non-small cell lung cancer with combination of chemotherapy and radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Big gulps: specialized membrane domains for rapid receptor-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Molecular targeting of drug delivery systems to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Phase I/II study of intraperitoneal floxuridine and platinums (cisplatin and/or carboplatin).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

An overview of silica in biology: its chemistry and recent technological advances

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Dysregulation of apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

siRNA therapy for cancer and non-lethal diseases such as arthritis and osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Surface-enhanced Raman scattering based nonfluorescent probe for multiplex DNA detection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

siRNA applications in nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Pulmonary versus systemic delivery of antibiotics: comparison of vancomycin dispositions in the isolated rat lung

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Mesoporous silica nanoparticles for intracellular controlled drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Reversal effect of Stephania tetrandra-containing Chinese herb formula SENL on multidrug resistance in lung cancer cell line SW1573/2R120.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Inhalation adjuvant therapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

The International Epidemiology of Lung Cancer: geographical distribution and secular trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

Characterization of chitosan thiolation and application to thiol quantification onto nanoparticle surface

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.622404

10.3109/1061186X.2011.622404

21 January 2018

Identifiers

DOI

1 reference

release_lfjhqkv36bcbhmuior2u4f4qe4

12 September 2017

0 references

1 reference